跳至主要内容
临床试验/CTRI/2024/12/078807
CTRI/2024/12/078807尚未招募2 期

Efficacy of Amal-e-kai in alleviating the pain of irqunnasa- A randomised controlled clinical trial

National Institute of Unani Medicine1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月10日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
40
试验地点
1
主要终点
VAS(VISUAL ANALOGUE SCALE)

研究概览

简要总结

Purpose- Efficacy of Amal-e-Kai in alleviating the pain of Irqunnasa(Sciatica)- A randomised controlled clinical trial

Intervention- In test group, to make the patient comfortable in prone position and the amal-e-kai is done in four points along the course of the respective sciatic nerve viz, over the hip joint postero-laterally, just above the knee joint line postero-laterally, 4cm above the lateral malleolus and lateral aspect of the little toe, done on 1st, 8th and 15th day(3 sittings in 15days)

control- In control group TENS is done over lower back and course of sciatic nerve over 20mins of duration on 1st, 8th and 15th day(3 sittings in 15days)

Study duration: 1year 6months

Main outcome measure:

Primary outcome: VAS (Visual Analogue Scale)

Secondary outcome: SBI (Sciatica Bothersomeness Index)

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.clinically diagnosed patients if sciatica 2.patient having pain in range of 3 to 7 on VAS 3.patient willing to take part in the study.

排除标准

  • 1.pregnant and lactating women 2.systemic illness such as cancer, DM, epilepsy, cardiac, liver, kidney and pulmonary diseases 3.Spinal injury and deformity(congenital/acquired) 4.who fail to give consent for trial.

结局指标

主要结局

VAS(VISUAL ANALOGUE SCALE)

时间窗: At baseline, 2 weeks

次要结局

  • SBI(Sciatica Bothersomeness Index)(At baseline, 2 weeks)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr. Dwarakeesha Chatrappa

National Institute of Unani Medicine, Bangalore

研究点 (1)

Loading locations...

相似试验